Pliant Therapeutics (PLRX)
(Delayed Data from NSDQ)
$10.91 USD
+0.36 (3.41%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $10.93 +0.02 (0.18%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.99 |
EPS Last Quarter | -0.92 |
Last EPS Surprise | -8.24% |
ABR | 1.14 |
Earnings ESP
|
-0.72% |
---|---|
Current Year | -3.71 |
Next Year | -4.03 |
EPS (TTM) | -3.09 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 1.58M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.99 | -0.97 | -3.71 | -4.03 |
# of Estimates | 7 | 6 | 8 | 7 |
Most Recent Consensus | -1.00 | -0.98 | -3.69 | -3.84 |
High Estimate | -0.90 | -0.89 | -3.49 | -3.59 |
Low Estimate | -1.15 | -1.05 | -4.15 | -4.96 |
Year ago EPS | -0.70 | -0.69 | -2.75 | -3.71 |
Year over Year Growth Est. | -41.43% | -40.58% | -34.91% | -8.56% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 0 |
Down Last 60 Days | 5 | 5 | 7 | 7 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.99 | -0.97 | -3.71 | -4.03 |
7 Days Ago | -0.99 | -0.97 | -3.71 | -4.03 |
30 Days Ago | -0.98 | -0.96 | -3.69 | -4.04 |
60 Days Ago | -0.88 | -0.90 | -3.44 | -3.71 |
90 Days Ago | -0.88 | -0.90 | -3.44 | -3.71 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.00 | -0.98 | -3.69 | -3.84 |
Zacks Consensus Estimate | -0.99 | -0.97 | -3.71 | -4.03 |
Earnings ESP | -0.72% | -0.69% | 0.57% | 4.68% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.92 | -0.78 | -0.69 | -0.70 | NA |
Estimate | -0.85 | -0.76 | NA | -0.78 | NA |
Difference | -0.07 | -0.02 | NA | 0.08 | 0.00 |
Surprise | -8.24% | -2.63% | NA | 10.26% | -0.20% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more